DK2812011T3 - Differentiering ex vivo af nk-celler fra cd34+ hæmatopoietiske celler - Google Patents
Differentiering ex vivo af nk-celler fra cd34+ hæmatopoietiske celler Download PDFInfo
- Publication number
- DK2812011T3 DK2812011T3 DK13709575.8T DK13709575T DK2812011T3 DK 2812011 T3 DK2812011 T3 DK 2812011T3 DK 13709575 T DK13709575 T DK 13709575T DK 2812011 T3 DK2812011 T3 DK 2812011T3
- Authority
- DK
- Denmark
- Prior art keywords
- cells
- differentizing
- vivo
- hematopoietic
- hematopoietic cells
- Prior art date
Links
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 title 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 title 1
- 210000004027 cell Anatomy 0.000 title 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4613—Natural-killer cells [NK or NK-T]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/145—Thrombopoietin [TPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/21—Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2306—Interleukin-6 (IL-6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2307—Interleukin-7 (IL-7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2312—Interleukin-12 (IL-12)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2315—Interleukin-15 (IL-15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
- C12N2501/91—Heparin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12154554 | 2012-02-08 | ||
PCT/NL2013/050073 WO2013119118A1 (en) | 2012-02-08 | 2013-02-07 | Ex vivo nk cell differentiation from cd34+ hematopoietic cells |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2812011T3 true DK2812011T3 (da) | 2020-02-24 |
Family
ID=47884461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13709575.8T DK2812011T3 (da) | 2012-02-08 | 2013-02-07 | Differentiering ex vivo af nk-celler fra cd34+ hæmatopoietiske celler |
Country Status (7)
Country | Link |
---|---|
US (3) | US20150010583A1 (da) |
EP (1) | EP2812011B1 (da) |
CA (1) | CA2864283C (da) |
DK (1) | DK2812011T3 (da) |
ES (1) | ES2771248T3 (da) |
PL (1) | PL2812011T3 (da) |
WO (1) | WO2013119118A1 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2972662A1 (en) * | 2014-12-31 | 2016-07-07 | Anthrogenesis Corporation | Natural killer cells and uses thereof |
WO2017042393A1 (en) * | 2015-09-11 | 2017-03-16 | Emercell Sas | Pooled nk cells from umbilical cord blood associated with antibodies and their uses for the treatment of disease |
EP3350316B1 (en) * | 2015-09-15 | 2024-05-08 | Stichting Radboud universitair medisch centrum | IMPROVED METHOD FOR EX VIVO EXPANSION CD34+HSPCs INTO NK CELLS USING AN ARYL HYDROCARBON RECEPTOR ANTAGONIST |
TW201732037A (zh) | 2015-10-15 | 2017-09-16 | 安瑟吉納西斯公司 | 自然殺手細胞及ilc3細胞及其用途 |
SG11201809858RA (en) * | 2016-05-07 | 2018-12-28 | Celularity Inc | Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cells |
IT201600121081A1 (it) * | 2016-11-29 | 2018-05-29 | Fond Ri Med | Immunoterapia NK-mediata e usi di essa |
JP6647240B2 (ja) * | 2017-05-12 | 2020-02-14 | 米満 吉和 | 高活性nk細胞、およびその利用 |
IL276365B2 (en) | 2018-02-01 | 2023-10-01 | Nkmax Co Ltd | A method for the production of natural killer cells and a preparation for cancer treatment |
CN108315299A (zh) * | 2018-02-13 | 2018-07-24 | 南京支云松生物科技有限公司 | 一种即用型异体nk细胞库网络储运应用*** |
CN112204133B (zh) * | 2018-05-30 | 2024-04-19 | 格雷克斯迪姆医疗私人有限公司 | Car nk细胞 |
JP2022514393A (ja) * | 2018-12-21 | 2022-02-10 | ステムセル テクノロジーズ カナダ インコーポレイテッド | ナチュラルキラー細胞に分化させるための培地および方法 |
CN113166726A (zh) | 2019-07-08 | 2021-07-23 | 南克维斯特公司 | 单核细胞源性nk细胞 |
US11453862B2 (en) | 2019-07-08 | 2022-09-27 | Immunitybio, Inc. | Mononuclear cell derived NK cells |
US20220249567A1 (en) * | 2019-07-22 | 2022-08-11 | Glycostem Therapeutics B.V. | Low density cell culture |
WO2021107779A1 (en) * | 2019-11-28 | 2021-06-03 | Glycostem Therapeutics B.V. | Method for obtaining car-nk cells |
US11591381B2 (en) | 2020-11-30 | 2023-02-28 | Crispr Therapeutics Ag | Gene-edited natural killer cells |
EP4271798A1 (en) | 2020-12-30 | 2023-11-08 | CRISPR Therapeutics AG | Compositions and methods for differentiating stem cells into nk cells |
CN113416700B (zh) * | 2021-07-09 | 2023-04-11 | 天晴干细胞股份有限公司 | 一种高效的因子分泌型nk细胞扩增方法及其应用 |
KR102504039B1 (ko) * | 2022-10-25 | 2023-03-02 | 오정훈 | 자연살해세포 증식에 효과적인 배양 방법 및 이의 용도 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006004592A2 (en) * | 2004-05-28 | 2006-01-12 | Mayo Foundation For Medical Education And Research | Methods for autologous stem cell transplantation |
WO2006102209A2 (en) * | 2005-03-18 | 2006-09-28 | The Ohio State University Research Foundation | Cd34(+) cells and their methods of use |
PT1941027E (pt) * | 2005-09-28 | 2014-10-09 | Ipd Therapeutics B V | Métodos e meios para proliferação de células estaminais e subsequente geração e expansão de células progenitoras, bem como produção de células efectoras como produtos terapêuticos clínicos |
DK2142642T3 (da) * | 2007-03-27 | 2017-09-11 | Ipd-Therapeutics B V | Fremgangsmåder og middel til stamcelleproliferation og efterfølgende generering og ekspansion af progenitorceller, såvel som produktion af effektorceller som kliniske terapeutika |
-
2013
- 2013-02-07 WO PCT/NL2013/050073 patent/WO2013119118A1/en active Application Filing
- 2013-02-07 DK DK13709575.8T patent/DK2812011T3/da active
- 2013-02-07 PL PL13709575T patent/PL2812011T3/pl unknown
- 2013-02-07 CA CA2864283A patent/CA2864283C/en active Active
- 2013-02-07 ES ES13709575T patent/ES2771248T3/es active Active
- 2013-02-07 EP EP13709575.8A patent/EP2812011B1/en active Active
- 2013-02-07 US US14/376,870 patent/US20150010583A1/en not_active Abandoned
-
2017
- 2017-09-21 US US15/711,141 patent/US10822589B2/en active Active
-
2020
- 2020-10-06 US US17/064,036 patent/US20210054338A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2864283C (en) | 2020-11-03 |
EP2812011B1 (en) | 2020-01-15 |
CA2864283A1 (en) | 2013-08-15 |
US10822589B2 (en) | 2020-11-03 |
ES2771248T3 (es) | 2020-07-06 |
PL2812011T3 (pl) | 2020-06-29 |
US20210054338A1 (en) | 2021-02-25 |
US20150010583A1 (en) | 2015-01-08 |
WO2013119118A1 (en) | 2013-08-15 |
US20180044636A1 (en) | 2018-02-15 |
EP2812011A1 (en) | 2014-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2812011T3 (da) | Differentiering ex vivo af nk-celler fra cd34+ hæmatopoietiske celler | |
SMT201500263B (it) | Composizioni solide | |
HK1207882A1 (en) | T cell receptor-deficient cell compositions t t | |
EP2939206A4 (en) | MANAGEMENT OF E-MAILS WITH PAYMENTS | |
FR2950069B1 (fr) | Utilisation de compositions ternaires | |
DK2640893T4 (da) | Sammensætninger | |
PT3023788T (pt) | Composições de neoantigénios específicos de tumor para utilização no tratamento de tumores | |
DK3354747T3 (da) | Ikke-invasiv bestemmelse af tumormethylom fra plasma | |
DK2911506T3 (da) | Driftreducerende sammensætninger | |
BR112014020543A8 (pt) | composições de ração e métodos de utilização das mesmas | |
DK3418396T3 (da) | Vurdering af cellulær signalvejsaktivitet under anvendelse af probabilistisk modellering af målgenekspression | |
BR112013017183A2 (pt) | composições de bepostatina | |
CO6930368A2 (es) | Composiciones de yodo-povidona estable | |
DK2931970T4 (da) | Cellulose-afledte sammensætninger | |
DK3156056T3 (da) | Farmaceutiske sammensætninger der består af sorbitanestere | |
DK2528602T4 (da) | Formuleringer af bendamustin | |
CO6980141A1 (es) | Compuestos y composiciones de poliglicerilo catónicos | |
DK2633006T3 (da) | Fremstilling af fornybart bio-destillat | |
CO6950470A2 (es) | Formulaciones derivadas de decitabina | |
DK2822568T3 (da) | Anvendelser af caseinsammensætninger | |
ITTO20110268A1 (it) | Composizione di maquillage. | |
DK2931842T3 (da) | Omdannelse af triacylglyceridholdige olier | |
FR2987600B1 (fr) | Nacelle aplatie de turboreacteur | |
DE112011104051A5 (de) | Kombi-Radsatzpresse | |
HK1198660A1 (en) | Replenishing compositions and methods of replenishing pretreatment compositions |